Practice Fusion partners with AstraZeneca

Practice Fusion, an electronic health record provider, partnered with AstraZeneca on a program to alert physicians about patients with asthma or chronic obstructive pulmonary disease whose care does not meet national clinical guidelines for those conditions.

There are about 520,000 patients with asthma and 262,000 patients with COPD whose care is recorded on Practice Fusion's platform, according to a Practice Fusion spokesman.

Interested in beyond-the-pill pacts? More info here.  

The program uses care guidelines established by the National Heart, Lung, and Blood Institute and the Global Initiative for Chronic Obstructive Lung Disease. Financial terms of the arrangement were not disclosed, the spokesman said.

The clinical decision alerts are labeled to reflect that AstraZeneca is the funding source, while the source of the alert cites the organizations that developed the clinical guidelines.

It's the second such partnership for Practice Fusion, which announced a similar program in 2014 partnering with Merck to notify physicians about patients who are eligible for a vaccination based on recommendations put out by the Centers for Disease Control and Prevention. Practice Fusion reported a 73% relative increase in the number of recorded vaccinations for patients 18 years old and older in a four-month test period.

About 112,000 medical professionals use Practice Fusion's EHR platform every month.


Next Article in Pharmaceutical